| UniProt ID | OSTP_HUMAN | |
|---|---|---|
| UniProt AC | P10451 | |
| Protein Name | Osteopontin | |
| Gene Name | SPP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 314 | |
| Subcellular Localization | Secreted. | |
| Protein Description | Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction.; Acts as a cytokine involved in enhancing production of interferon-gamma and interleukin-12 and reducing production of interleukin-10 and is essential in the pathway that leads to type I immunity.. | |
| Protein Sequence | MRIAVICFCLLGITCAIPVKQADSGSSEEKQLYNKYPDAVATWLNPDPSQKQNLLAPQNAVSSEETNDFKQETLPSKSNESHDHMDDMDDEDDDDHVDSQDSIDSNDSDDVDDTDDSHQSDESHHSDESDELVTDFPTDLPATEVFTPVVPTVDTYDGRGDSVVYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNGAYKAIPVAQDLNAPSDWDSRGKDSYETSQLDDQSAETHSHKQSRLYKRKANDESNEHSDVIDSQELSKVSREFHSHEFHSHEDMLVVDPKSKEEDKHLKFRISHELDSASSEVN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 24 | Phosphorylation | IPVKQADSGSSEEKQ CCCHHCCCCCHHHHH | 43.52 | 20068231 | |
| 26 | Phosphorylation | VKQADSGSSEEKQLY CHHCCCCCHHHHHHH | 38.23 | 28192239 | |
| 27 | Phosphorylation | KQADSGSSEEKQLYN HHCCCCCHHHHHHHH | 53.99 | 28192239 | |
| 33 | Phosphorylation | SSEEKQLYNKYPDAV CHHHHHHHHHCCCHH | 13.71 | 25072903 | |
| 36 | Phosphorylation | EKQLYNKYPDAVATW HHHHHHHCCCHHHHH | 11.60 | 25072903 | |
| 42 | O-linked_Glycosylation | KYPDAVATWLNPDPS HCCCHHHHHCCCCHH | 24.72 | OGP | |
| 42 | Phosphorylation | KYPDAVATWLNPDPS HCCCHHHHHCCCCHH | 24.72 | 25072903 | |
| 49 | O-linked_Glycosylation | TWLNPDPSQKQNLLA HHCCCCHHHHCCCCC | 58.34 | 76780001 | |
| 49 | Phosphorylation | TWLNPDPSQKQNLLA HHCCCCHHHHCCCCC | 58.34 | 29759185 | |
| 59 (in isoform 5) | O-linked_Glycosylation | - | 41.05 | OGP | |
| 59 (in isoform 5) | Phosphorylation | - | 41.05 | 28355574 | |
| 62 | Phosphorylation | LAPQNAVSSEETNDF CCCCCCCCCHHHCCH | 29.62 | 29255136 | |
| 62 (in isoform 5) | O-linked_Glycosylation | - | 29.62 | OGP | |
| 62 (in isoform 5) | Phosphorylation | - | 29.62 | 28355574 | |
| 63 | Phosphorylation | APQNAVSSEETNDFK CCCCCCCCHHHCCHH | 32.62 | 29255136 | |
| 66 | Phosphorylation | NAVSSEETNDFKQET CCCCCHHHCCHHHHC | 35.72 | 29255136 | |
| 73 | O-linked_Glycosylation | TNDFKQETLPSKSNE HCCHHHHCCCCCCCC | 41.28 | OGP | |
| 73 | Phosphorylation | TNDFKQETLPSKSNE HCCHHHHCCCCCCCC | 41.28 | 22199227 | |
| 75 | Phosphorylation | DFKQETLPSKSNESH CHHHHCCCCCCCCCC | 47.32 | 27251275 | |
| 76 | O-linked_Glycosylation | FKQETLPSKSNESHD HHHHCCCCCCCCCCC | 52.40 | OGP | |
| 76 | Phosphorylation | FKQETLPSKSNESHD HHHHCCCCCCCCCCC | 52.40 | 22199227 | |
| 78 | Phosphorylation | QETLPSKSNESHDHM HHCCCCCCCCCCCCC | 50.60 | 15869464 | |
| 79 | N-linked_Glycosylation | ETLPSKSNESHDHMD HCCCCCCCCCCCCCC | 59.53 | 15869464 | |
| 81 | Phosphorylation | LPSKSNESHDHMDDM CCCCCCCCCCCCCCC | 38.17 | 15869464 | |
| 89 | Phosphorylation | HDHMDDMDDEDDDDH CCCCCCCCCCCCCCC | 64.24 | 27251275 | |
| 99 | Phosphorylation | DDDDHVDSQDSIDSN CCCCCCCCCHHCCCC | 34.49 | 15869464 | |
| 102 | Phosphorylation | DHVDSQDSIDSNDSD CCCCCCHHCCCCCCC | 22.21 | 15869464 | |
| 105 | Phosphorylation | DSQDSIDSNDSDDVD CCCHHCCCCCCCCCC | 40.65 | 15869464 | |
| 106 | N-linked_Glycosylation | SQDSIDSNDSDDVDD CCHHCCCCCCCCCCC | 49.40 | 15869464 | |
| 108 | Phosphorylation | DSIDSNDSDDVDDTD HHCCCCCCCCCCCCC | 39.70 | 15869464 | |
| 117 | Phosphorylation | DVDDTDDSHQSDESH CCCCCCCCCCCCCCC | 26.66 | 15869464 | |
| 120 | Phosphorylation | DTDDSHQSDESHHSD CCCCCCCCCCCCCCC | 37.61 | 15869464 | |
| 123 | Phosphorylation | DSHQSDESHHSDESD CCCCCCCCCCCCCCC | 31.33 | 15869464 | |
| 126 | Phosphorylation | QSDESHHSDESDELV CCCCCCCCCCCCCHH | 37.34 | 15869464 | |
| 129 | Phosphorylation | ESHHSDESDELVTDF CCCCCCCCCCHHCCC | 41.18 | 15869464 | |
| 134 | O-linked_Glycosylation | DESDELVTDFPTDLP CCCCCHHCCCCCCCC | 44.54 | 15869464 | |
| 134 | Phosphorylation | DESDELVTDFPTDLP CCCCCHHCCCCCCCC | 44.54 | 15869464 | |
| 138 | O-linked_Glycosylation | ELVTDFPTDLPATEV CHHCCCCCCCCCCCC | 50.60 | 15869464 | |
| 138 | Phosphorylation | ELVTDFPTDLPATEV CHHCCCCCCCCCCCC | 50.60 | 15869464 | |
| 143 | O-linked_Glycosylation | FPTDLPATEVFTPVV CCCCCCCCCCCCCCC | 30.64 | 15869464 | |
| 143 | Phosphorylation | FPTDLPATEVFTPVV CCCCCCCCCCCCCCC | 30.64 | 15869464 | |
| 147 | O-linked_Glycosylation | LPATEVFTPVVPTVD CCCCCCCCCCCCCCC | 21.98 | 15869464 | |
| 147 | Phosphorylation | LPATEVFTPVVPTVD CCCCCCCCCCCCCCC | 21.98 | 15869464 | |
| 152 | O-linked_Glycosylation | VFTPVVPTVDTYDGR CCCCCCCCCCCCCCC | 21.28 | 15869464 | |
| 152 | Phosphorylation | VFTPVVPTVDTYDGR CCCCCCCCCCCCCCC | 21.28 | 15869464 | |
| 162 | O-linked_Glycosylation | TYDGRGDSVVYGLRS CCCCCCCCEEEECCC | 19.12 | OGP | |
| 162 | Dephosphorylation | TYDGRGDSVVYGLRS CCCCCCCCEEEECCC | 19.12 | 8195113 | |
| 162 | Phosphorylation | TYDGRGDSVVYGLRS CCCCCCCCEEEECCC | 19.12 | 28857561 | |
| 165 | Phosphorylation | GRGDSVVYGLRSKSK CCCCCEEEECCCCCC | 14.32 | - | |
| 181 | Phosphorylation | FRRPDIQYPDATDED CCCCCCCCCCCCCCH | 11.92 | 27251275 | |
| 185 | Phosphorylation | DIQYPDATDEDITSH CCCCCCCCCCHHHHH | 47.50 | 15869464 | |
| 190 | Phosphorylation | DATDEDITSHMESEE CCCCCHHHHHHHHHH | 25.54 | 30242111 | |
| 191 | Phosphorylation | ATDEDITSHMESEEL CCCCHHHHHHHHHHH | 22.59 | 15869464 | |
| 195 | Phosphorylation | DITSHMESEELNGAY HHHHHHHHHHHCCHH | 28.88 | 15869464 | |
| 202 | Phosphorylation | SEELNGAYKAIPVAQ HHHHCCHHHHCHHHH | 11.44 | 30242111 | |
| 203 | Phosphorylation | EELNGAYKAIPVAQD HHHCCHHHHCHHHHC | 39.03 | 27251275 | |
| 204 | Phosphorylation | ELNGAYKAIPVAQDL HHCCHHHHCHHHHCC | 9.91 | 27251275 | |
| 208 | Phosphorylation | AYKAIPVAQDLNAPS HHHHCHHHHCCCCCC | 7.57 | 27251275 | |
| 215 | O-linked_Glycosylation | AQDLNAPSDWDSRGK HHCCCCCCCCCCCCC | 49.26 | OGP | |
| 215 | Phosphorylation | AQDLNAPSDWDSRGK HHCCCCCCCCCCCCC | 49.26 | 15869464 | |
| 219 | Phosphorylation | NAPSDWDSRGKDSYE CCCCCCCCCCCCHHC | 38.38 | 19664994 | |
| 224 | Phosphorylation | WDSRGKDSYETSQLD CCCCCCCHHCCCCCC | 28.49 | 28355574 | |
| 225 | Phosphorylation | DSRGKDSYETSQLDD CCCCCCHHCCCCCCC | 33.10 | 25072903 | |
| 227 | O-linked_Glycosylation | RGKDSYETSQLDDQS CCCCHHCCCCCCCCC | 17.34 | OGP | |
| 227 | Phosphorylation | RGKDSYETSQLDDQS CCCCHHCCCCCCCCC | 17.34 | 25072903 | |
| 228 | O-linked_Glycosylation | GKDSYETSQLDDQSA CCCHHCCCCCCCCCH | 19.46 | OGP | |
| 228 | Phosphorylation | GKDSYETSQLDDQSA CCCHHCCCCCCCCCH | 19.46 | 15869464 | |
| 232 | Phosphorylation | YETSQLDDQSAETHS HCCCCCCCCCHHHHH | 53.58 | 27251275 | |
| 234 | O-linked_Glycosylation | TSQLDDQSAETHSHK CCCCCCCCHHHHHHH | 34.76 | OGP | |
| 234 | Phosphorylation | TSQLDDQSAETHSHK CCCCCCCCHHHHHHH | 34.76 | 29255136 | |
| 237 | O-linked_Glycosylation | LDDQSAETHSHKQSR CCCCCHHHHHHHHHH | 28.53 | OGP | |
| 237 | Phosphorylation | LDDQSAETHSHKQSR CCCCCHHHHHHHHHH | 28.53 | 29255136 | |
| 238 | Phosphorylation | DDQSAETHSHKQSRL CCCCHHHHHHHHHHH | 21.29 | 27251275 | |
| 239 | O-linked_Glycosylation | DQSAETHSHKQSRLY CCCHHHHHHHHHHHH | 39.54 | OGP | |
| 239 | Phosphorylation | DQSAETHSHKQSRLY CCCHHHHHHHHHHHH | 39.54 | 23911959 | |
| 240 | Phosphorylation | QSAETHSHKQSRLYK CCHHHHHHHHHHHHH | 25.27 | 27251275 | |
| 241 | Phosphorylation | SAETHSHKQSRLYKR CHHHHHHHHHHHHHH | 53.64 | 27251275 | |
| 243 | Phosphorylation | ETHSHKQSRLYKRKA HHHHHHHHHHHHHHC | 29.11 | 18702456 | |
| 246 | Phosphorylation | SHKQSRLYKRKANDE HHHHHHHHHHHCCCC | 13.98 | 24505115 | |
| 247 | Phosphorylation | HKQSRLYKRKANDES HHHHHHHHHHCCCCC | 52.60 | 27251275 | |
| 254 | Phosphorylation | KRKANDESNEHSDVI HHHCCCCCCCCCCCC | 50.83 | 29255136 | |
| 258 | Phosphorylation | NDESNEHSDVIDSQE CCCCCCCCCCCCHHH | 27.65 | 29255136 | |
| 263 | Phosphorylation | EHSDVIDSQELSKVS CCCCCCCHHHHHHHH | 17.90 | 29255136 | |
| 267 | O-linked_Glycosylation | VIDSQELSKVSREFH CCCHHHHHHHHHHHH | 30.20 | OGP | |
| 267 | Phosphorylation | VIDSQELSKVSREFH CCCHHHHHHHHHHHH | 30.20 | 15869464 | |
| 270 | Phosphorylation | SQELSKVSREFHSHE HHHHHHHHHHHHHCC | 29.81 | 15869464 | |
| 271 | Phosphorylation | QELSKVSREFHSHEF HHHHHHHHHHHHCCC | 54.29 | 27251275 | |
| 275 | Phosphorylation | KVSREFHSHEFHSHE HHHHHHHHCCCCCCC | 29.99 | 29255136 | |
| 276 | Phosphorylation | VSREFHSHEFHSHED HHHHHHHCCCCCCCC | 32.92 | 27251275 | |
| 280 | O-linked_Glycosylation | FHSHEFHSHEDMLVV HHHCCCCCCCCEEEE | 33.61 | OGP | |
| 280 | Phosphorylation | FHSHEFHSHEDMLVV HHHCCCCCCCCEEEE | 33.61 | 29255136 | |
| 283 | Phosphorylation | HEFHSHEDMLVVDPK CCCCCCCCEEEECCC | 30.23 | 27251275 | |
| 288 | Phosphorylation | HEDMLVVDPKSKEED CCCEEEECCCCHHHH | 37.11 | 27251275 | |
| 291 | Phosphorylation | MLVVDPKSKEEDKHL EEEECCCCHHHHHCH | 51.17 | 15869464 | |
| 293 | Phosphorylation | VVDPKSKEEDKHLKF EECCCCHHHHHCHHH | 77.76 | 27251275 | |
| 303 | O-linked_Glycosylation | KHLKFRISHELDSAS HCHHHHHHHHHHCCC | 13.47 | OGP | |
| 303 | Phosphorylation | KHLKFRISHELDSAS HCHHHHHHHHHHCCC | 13.47 | 19664994 | |
| 304 | Phosphorylation | HLKFRISHELDSASS CHHHHHHHHHHCCCC | 36.95 | 27251275 | |
| 308 | O-linked_Glycosylation | RISHELDSASSEVN- HHHHHHHCCCCCCC- | 42.55 | OGP | |
| 308 | Phosphorylation | RISHELDSASSEVN- HHHHHHHCCCCCCC- | 42.55 | 28355574 | |
| 310 | Phosphorylation | SHELDSASSEVN--- HHHHHCCCCCCC--- | 30.86 | 26503892 | |
| 311 | O-linked_Glycosylation | HELDSASSEVN---- HHHHCCCCCCC---- | 45.33 | OGP | |
| 311 | Phosphorylation | HELDSASSEVN---- HHHHCCCCCCC---- | 45.33 | 15869464 | |
| 316 | Phosphorylation | ASSEVN--------- CCCCCC--------- | 27251275 | ||
| 321 | Phosphorylation | N-------------- C-------------- | 27251275 | ||
| 323 | Phosphorylation | ---------------- ---------------- | 27251275 | ||
| 324 | Phosphorylation | ----------------- ----------------- | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 26 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 27 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 62 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 63 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 190 | T | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 191 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 195 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 215 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 219 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 224 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 228 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 234 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 237 | T | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 239 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 243 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 254 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 258 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 263 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 267 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 270 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 275 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 280 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 291 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 303 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 308 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 310 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 311 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OSTP_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Post-translationally modified residues of native human osteopontinare located in clusters: identification of 36 phosphorylation and fiveO-glycosylation sites and their biological implications."; Christensen B., Nielsen M.S., Haselmann K.F., Petersen T.E.,Sorensen E.S.; Biochem. J. 390:285-292(2005). Cited for: PHOSPHORYLATION AT SER-24; SER-26; SER-27; SER-62; SER-63; THR-66;SER-76; SER-81; SER-99; SER-102; SER-108; SER-117; SER-120; SER-123;SER-129; THR-185; SER-191; SER-195; SER-215; SER-219; SER-224;SER-228; SER-234; SER-254; SER-263; SER-267; SER-275; SER-280;SER-303; SER-308; SER-310; SER-105 AND SER-126, AND GLYCOSYLATION ATASN-79; ASN-106; THR-134; THR-138; THR-143; THR-147 AND THR-152. | |
| O-linked Glycosylation | |
| Reference | PubMed |
| "Post-translationally modified residues of native human osteopontinare located in clusters: identification of 36 phosphorylation and fiveO-glycosylation sites and their biological implications."; Christensen B., Nielsen M.S., Haselmann K.F., Petersen T.E.,Sorensen E.S.; Biochem. J. 390:285-292(2005). Cited for: PHOSPHORYLATION AT SER-24; SER-26; SER-27; SER-62; SER-63; THR-66;SER-76; SER-81; SER-99; SER-102; SER-108; SER-117; SER-120; SER-123;SER-129; THR-185; SER-191; SER-195; SER-215; SER-219; SER-224;SER-228; SER-234; SER-254; SER-263; SER-267; SER-275; SER-280;SER-303; SER-308; SER-310; SER-105 AND SER-126, AND GLYCOSYLATION ATASN-79; ASN-106; THR-134; THR-138; THR-143; THR-147 AND THR-152. | |
| Phosphorylation | |
| Reference | PubMed |
| "An initial characterization of the serum phosphoproteome."; Zhou W., Ross M.M., Tessitore A., Ornstein D., Vanmeter A.,Liotta L.A., Petricoin E.F. III; J. Proteome Res. 8:5523-5531(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219; SER-303; SER-308AND SER-310, TISSUE SPECIFICITY, AND MASS SPECTROMETRY. | |
| "Phosphoproteomic analysis of the human pituitary."; Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.; Pituitary 9:109-120(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND MASSSPECTROMETRY. | |
| "Post-translationally modified residues of native human osteopontinare located in clusters: identification of 36 phosphorylation and fiveO-glycosylation sites and their biological implications."; Christensen B., Nielsen M.S., Haselmann K.F., Petersen T.E.,Sorensen E.S.; Biochem. J. 390:285-292(2005). Cited for: PHOSPHORYLATION AT SER-24; SER-26; SER-27; SER-62; SER-63; THR-66;SER-76; SER-81; SER-99; SER-102; SER-108; SER-117; SER-120; SER-123;SER-129; THR-185; SER-191; SER-195; SER-215; SER-219; SER-224;SER-228; SER-234; SER-254; SER-263; SER-267; SER-275; SER-280;SER-303; SER-308; SER-310; SER-105 AND SER-126, AND GLYCOSYLATION ATASN-79; ASN-106; THR-134; THR-138; THR-143; THR-147 AND THR-152. | |